Medilink Therapeutics

About:

Medilink Therapeutics is a biotech company focusing on next-generation antibody-drug conjugate Research & development.

Website: https://www.medilinkthera.com

Top Investors: Qiming Venture Partners, Legend Capital, LYFE Capital, Highlight Capital, Apricot Capital

Description:

MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.